Company profile
Therachon company profile
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is headquartered in Basel, Switzerland, with research labs in Nice, France.
Business identity
- Website
- http://www.therachon.com/
- Contact email
- [email protected]
- Phone number
- +41798989209
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $1M-$10M
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Breíl, Grisons, Switzerland
- Postal code
- 4051
- Country code
- CH
- Continent
- Europe